Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Battery-free, fully implantable optofluidic cuff system for wireless optogenetic and pharmacological neuromodulation of peripheral nerves.

Zhang Y, Mickle AD, Gutruf P, McIlvried LA, Guo H, Wu Y, Golden JP, Xue Y, Grajales-Reyes JG, Wang X, Krishnan S, Xie Y, Peng D, Su CJ, Zhang F, Reeder JT, Vogt SK, Huang Y, Rogers JA, Gereau RW 4th.

Sci Adv. 2019 Jul 5;5(7):eaaw5296. doi: 10.1126/sciadv.aaw5296. eCollection 2019 Jul.

2.

Untangling a canopy of spinal itch circuits.

Grajales-Reyes JG, Samineni VK.

Pain. 2019 May;160(5):987-988. doi: 10.1097/j.pain.0000000000001537. No abstract available.

PMID:
30817439
3.

The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders.

Capó-Vélez CM, Morales-Vargas B, García-González A, Grajales-Reyes JG, Delgado-Vélez M, Madera B, Báez-Pagán CA, Quesada O, Lasalde-Dominicci JA.

Sci Rep. 2018 Jan 29;8(1):1829. doi: 10.1038/s41598-018-20271-x.

4.

Miniaturized, Battery-Free Optofluidic Systems with Potential for Wireless Pharmacology and Optogenetics.

Noh KN, Park SI, Qazi R, Zou Z, Mickle AD, Grajales-Reyes JG, Jang KI, Gereau RW 4th, Xiao J, Rogers JA, Jeong JW.

Small. 2018 Jan;14(4). doi: 10.1002/smll.201702479. Epub 2017 Dec 7.

5.

Optogenetic silencing of nociceptive primary afferents reduces evoked and ongoing bladder pain.

Samineni VK, Mickle AD, Yoon J, Grajales-Reyes JG, Pullen MY, Crawford KE, Noh KN, Gereau GB, Vogt SK, Lai HH, Rogers JA, Gereau RW 4th.

Sci Rep. 2017 Nov 20;7(1):15865. doi: 10.1038/s41598-017-16129-3.

6.

A Panel of Slow-Channel Syndrome Mice Reveals a Unique Locomotor Behavioral Signature.

Grajales-Reyes JG, García-González A, María-Ríos JC, Grajales-Reyes GE, Delgado-Vélez M, Báez-Pagán CA, Quesada O, Gómez CM, Lasalde-Dominicci JA.

J Neuromuscul Dis. 2017;4(4):341-347. doi: 10.3233/JND-170226.

PMID:
29036836
7.

Divergent Modulation of Nociception by Glutamatergic and GABAergic Neuronal Subpopulations in the Periaqueductal Gray.

Samineni VK, Grajales-Reyes JG, Copits BA, O'Brien DE, Trigg SL, Gomez AM, Bruchas MR, Gereau RW 4th.

eNeuro. 2017 Mar 29;4(2). pii: ENEURO.0129-16.2017. doi: 10.1523/ENEURO.0129-16.2017. eCollection 2017 Mar-Apr.

8.

Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics.

Park SI, Brenner DS, Shin G, Morgan CD, Copits BA, Chung HU, Pullen MY, Noh KN, Davidson S, Oh SJ, Yoon J, Jang KI, Samineni VK, Norman M, Grajales-Reyes JG, Vogt SK, Sundaram SS, Wilson KM, Ha JS, Xu R, Pan T, Kim TI, Huang Y, Montana MC, Golden JP, Bruchas MR, Gereau RW 4th, Rogers JA.

Nat Biotechnol. 2015 Dec;33(12):1280-1286. doi: 10.1038/nbt.3415. Epub 2015 Nov 9.

9.

Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.

Zhu H, Grajales-Reyes GE, Alicea-Vázquez V, Grajales-Reyes JG, Robinson K, Pytel P, Báez-Pagán CA, Lasalde-Dominicci JA, Gomez CM.

Exp Neurol. 2015 Aug;270:88-94. doi: 10.1016/j.expneurol.2014.10.008. Epub 2014 Oct 23.

10.

Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Cruz-Orengo L, Daniels BP, Dorsey D, Basak SA, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, Klein RS.

J Clin Invest. 2014 Jun;124(6):2571-84. doi: 10.1172/JCI73408. Epub 2014 May 8.

11.

Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions.

Grajales-Reyes GE, Báez-Pagán CA, Zhu H, Grajales-Reyes JG, Delgado-Vélez M, García-Beltrán WF, Luciano CA, Quesada O, Ramírez R, Gómez CM, Lasalde-Dominicci JA.

Pharmacogenomics J. 2013 Aug;13(4):362-8. doi: 10.1038/tpj.2012.21. Epub 2012 Jun 12.

Supplemental Content

Loading ...
Support Center